AU2021350099A1 - Zinc finger fusion proteins for nucleobase editing - Google Patents

Zinc finger fusion proteins for nucleobase editing Download PDF

Info

Publication number
AU2021350099A1
AU2021350099A1 AU2021350099A AU2021350099A AU2021350099A1 AU 2021350099 A1 AU2021350099 A1 AU 2021350099A1 AU 2021350099 A AU2021350099 A AU 2021350099A AU 2021350099 A AU2021350099 A AU 2021350099A AU 2021350099 A1 AU2021350099 A1 AU 2021350099A1
Authority
AU
Australia
Prior art keywords
seq
nos
domain
zfp
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2021350099A
Other languages
English (en)
Other versions
AU2021350099A9 (en
Inventor
Sebastian ARANGUNDY
Friedrich A. FAUSER
Jeffrey C. Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sangamo Therapeutics Inc
Original Assignee
Sangamo Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sangamo Therapeutics Inc filed Critical Sangamo Therapeutics Inc
Publication of AU2021350099A1 publication Critical patent/AU2021350099A1/en
Publication of AU2021350099A9 publication Critical patent/AU2021350099A9/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/04—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amidines (3.5.4)
    • C12Y305/04005—Cytidine deaminase (3.5.4.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2021350099A 2020-09-25 2021-09-24 Zinc finger fusion proteins for nucleobase editing Abandoned AU2021350099A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063083662P 2020-09-25 2020-09-25
US63/083,662 2020-09-25
US202163164893P 2021-03-23 2021-03-23
US63/164,893 2021-03-23
US202163230580P 2021-08-06 2021-08-06
US63/230,580 2021-08-06
PCT/US2021/052088 WO2022067122A1 (en) 2020-09-25 2021-09-24 Zinc finger fusion proteins for nucleobase editing

Publications (2)

Publication Number Publication Date
AU2021350099A1 true AU2021350099A1 (en) 2023-04-27
AU2021350099A9 AU2021350099A9 (en) 2023-07-13

Family

ID=78500694

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021350099A Abandoned AU2021350099A1 (en) 2020-09-25 2021-09-24 Zinc finger fusion proteins for nucleobase editing

Country Status (9)

Country Link
US (1) US20240043829A1 (cg-RX-API-DMAC7.html)
EP (1) EP4217479A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023542705A (cg-RX-API-DMAC7.html)
KR (1) KR20230074519A (cg-RX-API-DMAC7.html)
CN (1) CN116261594A (cg-RX-API-DMAC7.html)
AU (1) AU2021350099A1 (cg-RX-API-DMAC7.html)
CA (1) CA3196599A1 (cg-RX-API-DMAC7.html)
IL (1) IL301393A (cg-RX-API-DMAC7.html)
WO (1) WO2022067122A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022072393A1 (en) * 2020-09-29 2022-04-07 University Of Washington Use of a double-stranded dna cytosine deaminase for mapping dna-protein interactions
AU2023417456A1 (en) * 2022-12-30 2025-07-31 Peking University Nucleobase editor systems and methods of use thereof
WO2025128871A2 (en) 2023-12-13 2025-06-19 Renagade Therapeutics Management Inc. Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
WO2025174765A1 (en) 2024-02-12 2025-08-21 Renagade Therapeutics Management Inc. Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420032A (en) 1991-12-23 1995-05-30 Universitge Laval Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence
US5792632A (en) 1992-05-05 1998-08-11 Institut Pasteur Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
JP4012243B2 (ja) 1994-01-18 2007-11-21 ザ スクリップス リサーチ インスティチュート 亜鉛フィンガータンパク質誘導体およびそのための方法
US6140466A (en) 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
GB9824544D0 (en) 1998-11-09 1999-01-06 Medical Res Council Screening system
CA2196419C (en) 1994-08-20 2007-08-21 Yen Choo Improvements in or relating to binding proteins for recognition of dna
US5789538A (en) 1995-02-03 1998-08-04 Massachusetts Institute Of Technology Zinc finger proteins with high affinity new DNA binding specificities
US5925523A (en) 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
GB9710807D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
US6140081A (en) 1998-10-16 2000-10-31 The Scripps Research Institute Zinc finger binding domains for GNN
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US20020061512A1 (en) 2000-02-18 2002-05-23 Kim Jin-Soo Zinc finger domains and methods of identifying same
AU2001263155A1 (en) 2000-05-16 2001-11-26 Massachusetts Institute Of Technology Methods and compositions for interaction trap assays
JP2002060786A (ja) 2000-08-23 2002-02-26 Kao Corp 硬質表面用殺菌防汚剤
GB0108491D0 (en) 2001-04-04 2001-05-23 Gendaq Ltd Engineering zinc fingers
US20040224385A1 (en) 2001-08-20 2004-11-11 Barbas Carlos F Zinc finger binding domains for cnn
WO2006121866A2 (en) * 2005-05-05 2006-11-16 The Arizona Board Of Regents On Behalf Of The University Of Arizona Sequence enabled reassembly (seer) - a novel method for visualizing specific dna sequences
DK3246403T3 (da) 2005-10-18 2020-10-26 Prec Biosciences Rationelt designede meganucleaser med ændret sekvens-specificitet og dna-bindende affinitet
CA2725773C (en) 2008-05-28 2017-12-05 Sangamo Biosciences, Inc. Compositions for linking dna-binding domains and cleavage domains
JP6137596B2 (ja) 2010-02-08 2017-05-31 サンガモ セラピューティクス, インコーポレイテッド 遺伝子操作された切断ハーフドメイン
EP2566972B1 (en) 2010-05-03 2020-01-15 Sangamo Therapeutics, Inc. Compositions for linking zinc finger modules
AU2011256838B2 (en) 2010-05-17 2014-10-09 Sangamo Therapeutics, Inc. Novel DNA-binding proteins and uses thereof
EP3929279A1 (en) 2014-03-18 2021-12-29 Sangamo Therapeutics, Inc. Methods and compositions for regulation of zinc finger protein expression
IL264792B2 (en) 2016-08-24 2023-10-01 Sangamo Therapeutics Inc Engineered target-specific zinc-finger nucleases
CA3063733A1 (en) * 2017-05-25 2018-11-29 The General Hospital Corporation Base editors with improved precision and specificity
JP7541508B2 (ja) * 2018-08-23 2024-08-28 サンガモ セラピューティクス, インコーポレイテッド 操作された標的特異的な塩基エディター
CA3166153A1 (en) * 2020-01-28 2021-08-05 The Broad Institute, Inc. Base editors, compositions, and methods for modifying the mitochondrial genome
KR20240159025A (ko) * 2020-09-18 2024-11-05 기초과학연구원 표적화된 탈아미노효소 및 이를 이용한 염기 교정
CN117321197A (zh) * 2021-01-12 2023-12-29 马奇疗法公司 背景依赖性、双链dna特异性脱氨酶及其用途

Also Published As

Publication number Publication date
JP2023542705A (ja) 2023-10-11
EP4217479A1 (en) 2023-08-02
AU2021350099A9 (en) 2023-07-13
CA3196599A1 (en) 2022-03-31
CN116261594A (zh) 2023-06-13
KR20230074519A (ko) 2023-05-30
WO2022067122A1 (en) 2022-03-31
IL301393A (en) 2023-05-01
US20240043829A1 (en) 2024-02-08

Similar Documents

Publication Publication Date Title
US12084692B2 (en) Guide scaffolds
US20230076357A1 (en) Methods and Compositions for Directed Genome Editing
CN116497067B (zh) 治疗血红素病变的组合物和方法
US20240043829A1 (en) Zinc finger fusion proteins for nucleobase editing
US20220033858A1 (en) Crispr oligoncleotides and gene editing
JP2023510352A (ja) Pcsk9の標的化のための組成物および方法
CN116096885A (zh) 用于靶向C9orf72的组合物和方法
CA3225808A1 (en) Context-specific adenine base editors and uses thereof
US20250179468A1 (en) Direct replacement genome editing
WO2023023515A1 (en) Persistent allogeneic modified immune cells and methods of use thereof
WO2022120094A2 (en) Compositions and methods for the targeting of bcl11a
WO2020069029A1 (en) Novel crispr nucleases
CN120435553A (zh) 合成多肽及其用途
CN117561074A (zh) 腺苷脱氨酶变体及其用途
US20250361528A1 (en) Novel zinc finger fusion proteins for nucleobase editing
KR20240012377A (ko) 염기 편집기의 자기-불활성화용 조성물 및 방법
CN118234865A (zh) 持久性同种异体修饰免疫细胞及其使用方法
CN117813379A (zh) 包括crispr核酸酶的基因编辑系统和其用途
조성익 Genome editing in human mitochondrial DNA.
US20180238877A1 (en) Isolation of antigen specific b-cells

Legal Events

Date Code Title Description
SREP Specification republished
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period